Suchergebnisse - "Vedolizumab"

PubPharm (1.619)

1

Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab : a systematic review

enthalten in: Scandinavian journal of gastroenterology | 2024

von Forss, A. | Flis, P. | Sotoodeh, A. | +2

2

ENTERPRET : A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Jairath, V. | Yarur, A. | Osterman, M. | +6

3

Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease

enthalten in: Journal of pediatric gastroenterology and nutrition | 2024

von Rowland, P. | McNicol, M. | Kiel, A. | +5

4

Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease : Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study

enthalten in: Advances in therapy | 2024

von Yarur, A. | Mantzaris, G. | Wang, S. | +6

5

Early Versus Late Use of Vedolizumab in Ulcerative Colitis : Clinical, Endoscopic, and Histological Outcomes

enthalten in: Journal of Crohn's & colitis | 2024

von Vermeire, S. | Hanzel, J. | Löwenberg, M. | +38

6

Gut Immunomodulation with Vedolizumab prior to Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Inflammatory Bowel Disease

enthalten in: Transplantation and cellular therapy | 2024

von Chopra, Y. | Acevedo, K. | Muise, A. | +8

7

Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease

enthalten in: Digestive diseases and sciences | 2024

von Lamichhane, N. | Melas, N. | Bergqvist, V. | +8

8

Exposure-efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn's disease and ulcerative colitis

enthalten in: Expert review of clinical pharmacology | 2024

von D'Haens, G. | Rosario, M. | Polhamus, D. | +7

9

Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease : A Review of Comparative Effectiveness Studies

enthalten in: Journal of clinical medicine | 2024

von Sharip, M. | Nishad, N. | Pillay, L. | +3

10

Difficult-to-treat inflammatory bowel disease : Effectiveness and safety of 4th and 5th lines of treatment

enthalten in: United European gastroenterology journal | 2024

von Caron, B. | Habert, A. | Bonsack, O. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[162]